In vitro and in vivo activity of HER2-targeted antibody-liposomal doxorubicin conjugate MM-302 in HER2-intermediate tumors

被引：0
|
作者：
Geretti, E.
Espelin, C.
Adiwijaya, B.
Coma, S.
Koncki, Z.
Sumner, P.
Dumont, N.
Garcia, G.
Bloom, T.
Janovsky, J.
Reynolds, J.
Campbell, K.
Moyo, V.
Molnar, I.
LoRusso, P.
Krop, I.
Miller, K.
Ma, C.
Munster, P.
Wickham, T.
机构：
[1] Merrimack Pharmaceut Inc, Cambridge, MA USA
[2] Yale Canc Ctr, New Haven, CT USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P4-21-40
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-21-40
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging
    Kanazaki, Kengo
    Sano, Kohei
    Makino, Akira
    Shimizu, Yoichi
    Yamauchi, Fumio
    Ogawa, Satoshi
    Ding, Ning
    Yano, Tetsuya
    Temma, Takashi
    Ono, Masahiro
    Saji, Hideo
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (08) : 2051 - 2060
  • [32] Heregulin-induced resistance against HER2-targeted therapies in HER2 positive breast and gastric cancer in vitro and in vivo
    Nonagase, Yoshikane
    Yonesaka, Kimio
    Watanabe, Satomi
    Haratani, Koji
    Takahama, Takayuki
    Takegawa, Naoki
    Ueda, Hiroto
    Kawakami, Hisato
    Hayashi, Hidetoshi
    Takeda, Masayuki
    Sakamoto, Haruka
    Tamura, Takao
    Nakagawa, Kazuhiko
    Tsurutani, Junji
    CANCER RESEARCH, 2016, 76
  • [33] A basket trial of trastuzumab deruxtecan, a HER2-targeted antibody-drug conjugate, for HER2-amplified solid tumors identified by circulating tumor DNA analysis (HERALD trial).
    Yagisawa, Masataka
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    Komatsu, Yoshito
    Kadowaki, Shigenori
    Muro, Kei
    Sunakawa, Yu
    Satoh, Taroh
    Nishina, Tomohiro
    Esaki, Taito
    Fujii, Satoshi
    Ono, Hiromi
    Tomita, Daiki
    Fujishiro, Noriko
    Hirano, Nami
    Fuse, Nozomu
    Sato, Akihiro
    Ogawa, Gakuto
    Nomura, Shogo
    Taniguchi, Hiroya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] ABiparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
    Li, John Y.
    Perry, Samuel R.
    Muniz-Medina, Vanessa
    Wang, Xinzhong
    Wetzel, Leslie K.
    Rebelatto, Marlon C.
    Hinrichs, Mary Jane Masson
    Bezabeh, Binyam Z.
    Fleming, Ryan L.
    Dimasi, Nazzareno
    Feng, Hui
    Toader, Dorin
    Yuan, Andy Q.
    Xu, Lan
    Lin, Jia
    Gao, Changshou
    Wu, Herren
    Dixit, Rakesh
    Osbourn, Jane K.
    Coats, Steven R.
    CANCER CELL, 2016, 29 (01) : 117 - 129
  • [35] Single agent activity of ZW25, a HER2-targeted bispecific antibody, in HER2-expressing gastroesophageal and other cancers
    Beeram, M.
    Hamilton, E.
    Hanna, D.
    Ajani, J.
    Murphy, M. Blum
    Bendell, J.
    El-Khoueiry, A.
    Hausman, D.
    Lenz, H. J.
    Patnaik, A.
    Press, M.
    Rowse, G.
    Thimmarayappa, J.
    Meric-Bernstam, F.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E17 - E17
  • [36] In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody
    Ding, Ning
    Sano, Kohei
    Kanazaki, Kengo
    Ohashi, Manami
    Deguchi, Jun
    Kanada, Yuko
    Ono, Masahiro
    Saji, Hideo
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (06) : 870 - 876
  • [37] HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells
    Xia, Leiming
    Wen, Lu
    Qin, You
    Dobson, Hannah E.
    Zhang, Tao
    Comer, Frank, I
    Hinrichs, Mary Jane
    Oberst, Michael D.
    Coats, Steven R.
    Chang, Alfred E.
    Liu, Yuanyuan
    Bao, Yangyi
    Dai, Fu
    Wicha, Max S.
    Li, Qiao
    CELL CHEMICAL BIOLOGY, 2021, 28 (05): : 610 - +
  • [38] In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody
    Ning Ding
    Kohei Sano
    Kengo Kanazaki
    Manami Ohashi
    Jun Deguchi
    Yuko Kanada
    Masahiro Ono
    Hideo Saji
    Molecular Imaging and Biology, 2016, 18 : 870 - 876
  • [39] Single agent activity of ZW25, a HER2-targeted bispecific antibody, in heavily pretreated HER2-expressing cancers.
    Meric-Bernstam, Funda
    Beeram, Murali
    Mayordomo, Jose Ignacio
    Hanna, Diana L.
    Ajani, Jaffer A.
    Murphy, Mariela A. Blum
    Murthy, Rashmi Krishna
    Piha-Paul, Sarina Anne
    Bauer, Todd Michael
    Bendell, Johanna C.
    El-Khoueiry, Anthony B.
    Lenz, Heinz-Josef
    Press, Michael F.
    Royer, Nels
    Hausman, Diana Felice
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Development of a competitive ELISA for the quantification of F5 conjugate in HER2-targeted STEALTH immunoliposome doxorubicin in plasma samples
    Hu, Ran
    Davis, Rebecca
    Yao, Yongjin
    Xu, Yaodong
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2006, 386 (06) : 1657 - 1664
12345